Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 16 of 100
Finance
Meet Europe’s answer to the ‘Magnificent 7’—the high-flying ‘Granolas’ that Goldman Sachs is betting will prosper in the continent’s flatlining economy
By
Ryan Hogg
March 3, 2024
Lifestyle
Novo Nordisk faces competition close to home as Danish rival Zealand Pharma’s shares jump 35% on ‘groundbreaking’ weight-loss drug trial results
By
Prarthana Prakash
February 27, 2024
Newsletters
Denmark, home to Ozempic-maker Novo Nordisk, is now Europe’s third-most prosperous economy
By
Peter Vanham
and
Nicholas Gordon
February 27, 2024
Commentary
Sanofi CEO: AI promises a great era of drug discovery that could fundamentally change medicine–but only if we allow it to deliver
By
Paul Hudson
February 19, 2024
Patients see first savings from Biden’s drug price push, as Pharma lines up its lawyers
By
Arthur Allen
and
KFF Health News
February 16, 2024
Health
As cancer treatment advances, advocates push back against ‘maximum tolerated dose,’ citing patient suffering
By
Carla K. Johnson
and
The Associated Press
February 6, 2024
Health
Experimental once-a-month weight loss injectable shows lasting results in early study
By
Madison Muller
and
Bloomberg
February 5, 2024
U.S. drug price negotiations are underway. Here’s what that will mean for you—eventually
By
Chris Morris
February 2, 2024
Health
Weight-loss injectables like Zepbound are making as big of a splash as Viagra, if not bigger. What you need to know about the ‘miracle drugs’
By
Emma Court
,
Madison Muller
and
Bloomberg
January 31, 2024
Politics
‘We are using all the tools we have’: Lina Khan’s FTC takes aim at Big Pharma’s ‘patent thickets’, arguing they keep old drugs too pricey
By
Elisabeth Rosenthal
and
KFF Health News
January 31, 2024
Features
What losing vision in one eye helped me understand about animal research
By
Erika Fry
January 27, 2024
Features
Why Big Pharma can’t quit the lab monkey business
By
Erika Fry
January 27, 2024
Magazine
Big Pharma’s great lab monkey shortage: A crackdown on smuggling is causing chaos in America’s vital drug development pipeline
By
Erika Fry
January 27, 2024
Health
FDA allows imports of French syphilis drug alternate during US penicillin shortage
By
Ike Swetlitz
and
Bloomberg
January 10, 2024
Lifestyle
Gen X drugmaker is coughing up millions for Paris Olympics sponsorship to show Gen Z and millennials it’s a cool place to work
By
Prarthana Prakash
January 10, 2024
Most Popular
Future of Work
Ford CEO has 5,000 open mechanic jobs with up to 6-figure salaries from the shortage of manually skilled workers: 'We...
By
Marco Quiroz-Gutierrez
Economy
'I just don't have a good feeling about this': Top economist Claudia Sahm says the economy quietly shifted and...
By
Eleanor Pringle
Success
Ryan Serhant starts work at 4:30 a.m.—he says most people don’t achieve their dreams because ‘what they really want is...
By
Preston Fore